University of Groningen / Rijksuniversiteit Groningen
University / College
Location:
Groningen,
Netherlands (NL)
ISNI: 0000000404071981
ROR: https://ror.org/012p63287
Book Reviews (2019)
Westendorp M, Reinhardt B, Román RL, Bialeki J, Agadjanian A, Lauterbach K, Rivera Andía JJ, et al.
Journal article
Photophysical and electronic properties of bismuth-perovskite shelled lead sulfide quantum dots (2019)
Abdu-Aguye M, Bederak D, Kahmann S, Killilea NA, Sytnyk M, Heiß W, Loi MA
Journal article
Voltage-Dependent Photoluminescence and How It Correlates with the Fill Factor and Open-Circuit Voltage in Perovskite Solar Cells (2019)
Stolterfoht M, Le Corre VM, Feuerstein M, Caprioglio P, Koster LJA, Neher D
Journal article
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways (2019)
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, et al.
Journal article
CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum (2019)
Konrad E, Nardini N, Caliebe A, Nagel I, Young D, Horvath G, Santoro SL, et al.
Journal article
Reliability of charge carrier recombination data determined with charge extraction methods (2019)
Kniepert J, Paulke A, Perdigón-Toro L, Kurpiers J, Zhang H, Gao F, Yuan J, et al.
Journal article
Opinion of the Scientific Committee on Consumer safety (SCCS) – Opinion on the safety of cosmetic ingredient salicylic acid (CAS 69-72-7) (2019)
Panteri E, Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, et al.
Journal article
Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial (2019)
Stone J, Spotswood H, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al.
Conference contribution
Long-Term Outcome of Tocilizumab for Patients with Giant Cell Arteritis: Results from Part 2 of a Randomized Controlled Phase 3 Trial (2019)
Stone J, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al.
Conference contribution
Maintained Benefit in Health-Related Quality of Life of Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone Tapering: Results from the Open-Label, Long-Term Extension of a Phase 3 Randomized Controlled Trial (2019)
Stone J, Han J, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al.
Conference contribution